These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38670720)

  • 21. Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort.
    Ceccarelli F; Natalucci F; Picciariello L; Cirillo A; Olivieri G; Veroli M; Pisegna S; Ciancarella C; Gelibter A; Picone V; Santini D; Botticelli A; Conti F
    Clin Exp Med; 2024 Apr; 24(1):72. PubMed ID: 38598028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of immune checkpoint blockade on the outcomes of allogeneic hematopoietic stem cell transplantation.
    Hu Y; Wang Y; Min K; Zhou H; Gao X
    Front Immunol; 2024; 15():1491330. PubMed ID: 39635535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bispecific therapeutics: a state-of-the-art review on the combination of immune checkpoint ‎inhibition with costimulatory and non-checkpoint targeted therapy.
    Mortaheb S; Pezeshki PS; Rezaei N
    Expert Opin Biol Ther; 2024 Dec; 24(12):1335-1351. PubMed ID: 39503381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stevens-Johnson syndrome and toxic epidermal necrolysis-like eruptions in patients treated with immune checkpoint inhibitors: a systematic review.
    Akpala CO; Erfani YJ; Young J; Saeidi V; Todd A; Chelf C; Philips EJ; Alavi A
    Int J Dermatol; 2024 Dec; 63(12):e397-e404. PubMed ID: 39279714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of immune-related adverse events in U.S. veterans treated with immune checkpoint inhibitors.
    Krall C; Tague M; Lund BC
    J Oncol Pharm Pract; 2024 Dec; 30(8):1372-1377. PubMed ID: 38192067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timed intercourse for couples trying to conceive.
    Gibbons T; Reavey J; Georgiou EX; Becker CM
    Cochrane Database Syst Rev; 2023 Sep; 9(9):CD011345. PubMed ID: 37709293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effectiveness and safety of imported and domestic immune checkpoint inhibitors in China: A systematic review and pairwise and network meta-analyses.
    Peng J; Wang Y; Chi Z; Li S; Zhang Y; Li L; Bian D; Zhai Z; Yuan S; Zhang Y; Li W; Ye F; Wang L
    Pharmacol Res; 2024 Dec; 210():107475. PubMed ID: 39571771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases.
    Buch MH; Mallat Z; Dweck MR; Tarkin JM; O'Regan DP; Ferreira V; Youngstein T; Plein S
    Nat Rev Rheumatol; 2024 Oct; 20(10):614-634. PubMed ID: 39232242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease.
    Redfern J; Tu Q; Hyun K; Hollings MA; Hafiz N; Zwack C; Free C; Perel P; Chow CK
    Cochrane Database Syst Rev; 2024 Mar; 3(3):CD011851. PubMed ID: 38533994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare, but Severe: Vasculitis and Checkpoint Inhibitors.
    Lindner AK; Gruenbacher G; Schachtner G; Thurnher M; Pichler R
    Eur Urol Focus; 2020 May; 6(3):609-612. PubMed ID: 31072806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D supplementation for women during pregnancy.
    Palacios C; Kostiuk LL; Cuthbert A; Weeks J
    Cochrane Database Syst Rev; 2024 Jul; 7(7):CD008873. PubMed ID: 39077939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab for maintenance of medically-induced remission in Crohn's disease.
    Gordon M; Sinopoulou V; Akobeng AK; Sarian A; Moran GW
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD012609. PubMed ID: 38372447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab.
    Yoshimura A; Nagahara A; Ishizuya Y; Yamamoto Y; Hatano K; Kawashima A; Nakai Y; Nakayama M; Nishimura K; Nonomura N; Kato T
    Clin Exp Med; 2024 May; 24(1):111. PubMed ID: 38780659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of near-term prediction models for severe immune-related adverse events in malignant tumor PD-1 inhibitor therapy.
    Du Y; Zhang Y; Zhao W; Zhang Y; Su F; Zhang X; Li W; Hu W; Li Y; Zhao J
    Hum Vaccin Immunother; 2024 Dec; 20(1):2398309. PubMed ID: 39267589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomograms based on ratio indexes to predict severity and prognosis in immune checkpoint inhibitors-related myocarditis: a retrospective analysis.
    Li Z; Yao T; Liu G; Guan Z; Liu J; Guo L; Ma J
    J Cancer Res Clin Oncol; 2024 May; 150(5):277. PubMed ID: 38801421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ophthalmic Immune-Related Adverse Events and Association with Survival: Results From a Real-World Database.
    Quiruz L; Yavari N; Kikani B; Gupta AS; Wai KM; Kossler AL; Ludwig C; Koo EB; Rahimy E; Mruthyunjaya P
    Am J Ophthalmol; 2024 Dec; 268():348-359. PubMed ID: 39271090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review.
    Dhanasekaran P; Karasu BT; Mak A
    Rheumatol Int; 2024 Dec; 44(12):2757-2794. PubMed ID: 39576327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.